MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key

Haowei He1, Linhui Wang2, Wenquan Zhou1

  • 1Department of Urology, Jinling Hospital, Nanjing University Medical School, Nanjing, Jiangsu, China.

Plos One
|May 5, 2015
PubMed
Abstract

Insights

This study identified 11 dysregulated microRNAs (miRNAs) in clear cell renal cell carcinoma (ccRCC), with miR-199a-5p, miR-22, and miR-429 identified as key regulators. miR-199a-5p inhibits ccRCC cell invasion by targeting TGFBR1 and JunB.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Clear cell renal cell carcinoma (ccRCC) is a significant subtype of kidney cancer.
  • MicroRNA (miRNA) dysregulation is implicated in various cancers, including ccRCC.

Purpose of the Study:

  • To profile miRNA expression in ccRCC.
  • To identify key regulatory miRNAs in ccRCC pathogenesis.
  • To investigate the functional role of specific miRNAs in ccRCC progression.

Main Methods:

  • miRNA expression profiling using miRNA arrays on ccRCC tumor and adjacent normal tissues.
  • Bioinformatic analysis including Gene Ontology and KEGG pathway enrichment.
  • MicroRNA-gene network analysis to identify key regulatory miRNAs.
  • Validation of miRNA dysregulation in patient samples and cell lines.
  • Functional assays (cell invasion assays, luciferase reporter assays) to determine miRNA function and target interaction.

Main Results:

  • Eleven miRNAs were found to be commonly dysregulated in ccRCC tissues compared to normal tissues.
  • Three miRNAs (miR-199a-5p, miR-22, miR-429) were identified as key regulatory miRNAs.
  • Overexpression of miR-199a-5p significantly inhibited the invasion ability of ccRCC cells.
  • miR-199a-5p directly targets and suppresses the expression of TGFBR1 and JunB.

Conclusions:

  • This study identified 11 dysregulated miRNAs in ccRCC, highlighting miR-199a-5p, miR-22, and miR-429 as potentially crucial in ccRCC development.
  • miR-199a-5p demonstrates a significant role in suppressing ccRCC cell invasion by targeting TGFBR1 and JunB, suggesting its potential as a therapeutic target.